Mathilde Gravez graduated from the School of Chemistry, Polymers and Materials (ECPM) of Strasbourg, with a specialization in organic chemistry (2024). During her studies, Mathilde acquired skills in medicinal chemistry, particularly through a double degree at the University of Sherbrooke, where she completed her final-year internship on Parkinson’s disease. Subsequently, Mathilde worked for six months at the Sustainable Chemistry and Health Laboratory in Lille on a project focused on the synthesis of heterocyclic compounds for the treatment of chronic inflammatory bowel diseases.Mathilde is now starting a PhD on the development and physicochemical and pharmacokinetic optimization of kallikrein 6 inhibitors for the treatment of multiple sclerosis, under the supervision of Professor Nicolas Masurier.